Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,018 total articles
Silver Lake Technology Investors V, L.P., an entity associated with the private equity firm Silver Lake Group and Dell Technologies director Egon Durban, reported a disposition of Class C Common Stock totaling $627,442 on June 1, 2026. This transaction occurred as Dell stock has seen substantial gains over the past year. Despite this insider sellin…
The reported transactions of Fold Holdings' Chief Technology Officer, Thomas J. Dickman, highlight both unit conversions and a small-scale sale of common stock. These moves occurred against a backdrop of significant corporate activity for the company, including recent first-quarter 2026 financial results that missed expectations and the establishme…
William Brian Poppic Reeves, the CEO and a ten percent owner of Fold Holdings, Inc. (FLD), recently reported specific stock sales to cover tax obligations associated with vested restricted units. These transactions occurred against a backdrop of company financial performance that missed market expectations, even as the firm secured a new credit fac…
Dell Technologies director Egon Durban and affiliated entities linked to Silver Lake Technology reported selling a total of $1.39 million in Dell Class C Common Stock on June 1, 2026. The transactions occurred while the company's stock had shown substantial appreciation over the past year and week. Reports also highlight recent robust financial res…
Bloom Energy director John T. Chambers executed a Rule 10b5-1 plan sale of approximately $16.37 million in stock on May 28, 2026. This transaction occurs against a backdrop of significant positive analyst coverage, where multiple firms raised price targets following the company's strong quarterly earnings and expanded strategic agreements, although…
The Magnetar entities sold a substantial volume of CoreWeave, Inc. (CRWV) Class A Common Stock in early June 2026. Despite this reported insider selling activity, the article highlights several positive operational updates for CoreWeave, including major debt financing, enhanced cloud infrastructure, and favorable analyst ratings that point to conti…
Scott L. Burrows, Chief Financial Officer at Spyre Therapeutics, Inc., executed significant stock transactions on June 1, 2026. These sales, totaling $532,936, were conducted under a pre-arranged Rule 10b5-1 trading plan. The timing of this activity coincides with the company's stock price trading near its 52-week high and following a substantial y…
Silver Lake Technology Investors V, L.P., a component of the broader Silver Lake investment group, executed a significant sale of Dell Technologies Inc.'s Class C Common Stock on June 1, 2026. This transaction occurred against a backdrop of strong company performance, highlighted by impressive first-quarter fiscal 2027 results and robust analyst co…
The recent activity surrounding Spyre Therapeutics, Inc. (NASDAQ:SYRE) reveals a combination of executive selling, significant capital raises through public offerings, and material progress in clinical development programs. Specifically, CEO Cameron Turtle sold shares under an established trading plan while the company simultaneously completed majo…
A significant insider transaction was reported by a key director, Bob R. Simpson, who acquired $8.23 million worth of common units in TXO Partners. This buying activity occurs against a backdrop of active strategic maneuvering within the energy sector, including major asset divestitures and updated analyst coverage for TXO Energy Partners.
Entities connected to Silver Lake Group, L.L.C. reported selling a total value of approximately $604,717 worth of Dell Technologies Inc. (NYSE:DELL) Class C Common Stock on June 1, 2026. This transaction was filed via an SEC Form 4 filing. On the same date, these affiliates also converted shares of Class B Common Stock into Class C Common Stock, th…
Entities linked to Dell Technologies director Egon Durban and the investment firm Silver Lake Group, L.L.C., completed a notable divestiture of Dell Class C Common Stock on June 1, 2026. This transaction occurred while Dell shares were trading near their 52-week high of $469.47, following substantial gains over the past year. The sale involves mult…
Affiliated entities connected to Silver Lake Group, L.L.C., including director Egon Durban, sold approximately $34.9 million worth of Dell Class C Common Stock on June 1, 2026. This transaction occurred despite the stock having surged significantly over the past year and following recent positive analyst reports regarding Dell's financial performan…
Entities linked to Silver Lake Group, L.L.C., including director Egon Durban, executed sales totaling $36.4 million worth of Dell Technologies' Class C Common Stock on June 1, 2026. These transactions occurred while Dell shares were trading near their 52-week peak and following reports of the company exceeding financial expectations.
Affiliates of Silver Lake Group reported a recent sale of Class C Common Stock in Dell Technologies. This transaction occurred amidst significant upward momentum for the stock over the past year. Furthermore, recent financial disclosures, including first-quarter fiscal 2027 results showing an 88% revenue increase, have prompted multiple analyst fir…
Silver Lake Partners IV, L.P., a major private equity investor in Dell Technologies Inc., reported the sale of a significant block of Class C Common Stock on June 1, 2026. The transaction suggests a divestment near historical highs, occurring alongside positive market reactions to recent strong quarterly earnings and continued institutional interes…
Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., executed a sale of common stock shares totaling $655,294 on June 1, 2026. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan. The report also details several recent corporate milestones for Natera, including enhancements to its Panorama prenatal test an…
Alon Zvi, CEO and Chairperson of Tigo Energy, Inc. (NASDAQ:TYGO), executed multiple transactions between June 1 and June 3, 2026, selling common stock valued at approximately $785,597.These sales were conducted after the exercise of stock options, which allowed Mr. Zvi to acquire shares at a low cost basis of $0.56 per share. The sold shares ranged…
Silver Lake Partners IV, L.P., an affiliate of Silver Lake Group, L.L.C., executed a sale of Dell Technologies Inc.'s Class C Common Stock totaling approximately $37.7 million on June 1, 2026. The reported transaction involved the disposition of 75,331 shares, with prices ranging between $431.98 and $452.12 per share.This divestment occurs against …
Mariam Sorond, the Chief Executive Officer, President, and Director of NextNav Inc. (NASDAQ:NN), recently sold a total value of $1,391,425 worth 69,853 shares of company common stock on June 1, 2026. The sales were executed through two separate transactions utilizing a Rule 10b5-1 selling plan adopted by Sorond on December 22, 2025.This reported in…
Enovis CORP's Chief Administrative Officer, Oliver Engert, recently acquired a block of common stock, an action reported via SEC filing. This insider buying occurs against a backdrop of market price fluctuations for the stock. Furthermore, Enovis announced robust first-quarter 2026 financial results, including adjusted earnings per share and revenu…
Christopher Sarchi, Chief Commercial Officer of Replimune Group, Inc., recently executed a substantial stock sale. This activity occurs against a backdrop of significant regulatory progress concerning the company's Biologics License Application (BLA) for RP1 in combination with nivolumab. The FDA has committed to treating this resubmission as an ur…
Tracy D. Pagliara, a director at Westwater Resources, Inc., sold shares of the company's common stock totaling $15,049 on June 1, 2026. This transaction occurred as the stock has seen significant decline over the past six months and following the release of first-quarter 2026 earnings that posted a net loss.
David E. Cohen, a director at Evommune, Inc., recently sold a total of $123,093 worth of common stock through a pre-arranged trading plan. Concurrently, the filings detail his acquisition of 15,673 stock options. This activity is reported against a backdrop of recent company news, including the Q1 loss surpassing expectations and an analyst reitera…
The recent sale of common stock by Evommune's President & CEO, Luis C. Pena, signals specific insider activity while the company navigates mixed financial results and positive developments in its drug development pipeline. The transaction details are provided alongside current market data, analyst ratings, and updates regarding a Phase 2b trial.
